BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3197020)

  • 1. Drug-induced catatonia.
    Herrmann N; Lieff SJ
    Can J Psychiatry; 1988 Oct; 33(7):633-4. PubMed ID: 3197020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catatonic symptoms as a side effect of neuroleptic treatment].
    Gaertner HJ; Hörner W; Bartels M
    Nervenarzt; 1983 May; 54(5):250-4. PubMed ID: 6866168
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
    Stoudemire A; Luther JS
    Int J Psychiatry Med; 1984; 14(1):57-63. PubMed ID: 6145675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant catatonia in dementia with Lewy Body successfully treated with sismotherapy: A case report].
    Dhote J; Kipman A; Gasnier M
    Encephale; 2020 Apr; 46(2):155-157. PubMed ID: 31761312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    Teusink JP; Alexopoulos GS; Shamoian CA
    Am J Psychiatry; 1984 Jan; 141(1):118-9. PubMed ID: 6691428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catatonic-like syndrome during neuroleptic therapy.
    Nakra BR; Hwu HG
    Psychosomatics; 1982 Jul; 23(7):769-70. PubMed ID: 7122807
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol vs. phenelzine in continuation therapy of borderline disorder.
    Cornelius JR; Soloff PH; George A; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1993; 29(2):333-7. PubMed ID: 8290683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic-induced catatonic symptoms.
    Cremona-Barbaro A
    Br J Psychiatry; 1983 Jan; 142():98-9. PubMed ID: 6831138
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of phenelzine in geriatric depression.
    Lazarus LW; Groves L; Gierl B; Pandey G; Javaid JI; Lesser J; Ha YS; Davis J
    Biol Psychiatry; 1986 Jun; 21(7):699-701. PubMed ID: 3708040
    [No Abstract]   [Full Text] [Related]  

  • 13. Delusional parasitosis associated with phenelzine.
    Aizenberg D; Schwartz B; Zemishlany Z
    Br J Psychiatry; 1991 Nov; 159():716-7. PubMed ID: 1756352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous lorazepam in neuroleptic-induced catatonia.
    Fricchione GL; Cassem NH; Hooberman D; Hobson D
    J Clin Psychopharmacol; 1983 Dec; 3(6):338-42. PubMed ID: 6139391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitor-induced speech blockage.
    Goldstein DM; Goldberg RL
    J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradycardia induced by an interaction between phenelzine and beta blockers.
    Reggev A; Vollhardt BR
    Psychosomatics; 1989; 30(1):106-8. PubMed ID: 2913594
    [No Abstract]   [Full Text] [Related]  

  • 18. Mania associated with high percentage of inhibition of monoamine oxidase.
    Bowden CL; Seleshi E; Javors MA
    Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychomotor status with catatonic stupor following high dosage neuroleptic therapy].
    Fischer W; Rabending G
    Psychiatr Neurol Med Psychol (Leipz); 1986 Apr; 38(4):222-8. PubMed ID: 3737780
    [No Abstract]   [Full Text] [Related]  

  • 20. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
    Weinberger DR; Kelly MJ
    J Nerv Ment Dis; 1977 Oct; 165(4):263-8. PubMed ID: 908924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.